{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:49:56Z","timestamp":1792090196237,"version":"4.4.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11060-026-05779-x","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:49:40Z","timestamp":1789739380000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic modulation of glioblastoma by dietary intervention: a systematic review"],"prefix":"10.1007","volume":"179","author":[{"given":"Maged T.","family":"Ghoche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Mantica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Agnihotri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel K.","family":"McBrayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalil G.","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"issue":"5","key":"5779_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.5114\/wo.2014.40559","volume":"5","author":"K Urba\u0144ska","year":"2014","unstructured":"Urba\u0144ska K, Soko\u0142owska J, Szmidt M, Sysa P (2014) Review glioblastoma multiforme \u2013 an overview. wo 5(5):307\u2013312. https:\/\/doi.org\/10.5114\/wo.2014.40559","journal-title":"wo"},{"key":"5779_CR2","doi-asserted-by":"publisher","unstructured":"Urhie O, Turner R, Lucke-Wold B, Radwan W, Ahn J, Gyure K, Bhatia S (2018 Jul) Glioblastoma survival outcomes at a tertiary hospital in Appalachia: factors impacting the survival of patients following implementation of the stupp protocol. World Neurosurg 115:e59\u2013e66. https:\/\/doi.org\/10.1016\/j.wneu.2018.03.163","DOI":"10.1016\/j.wneu.2018.03.163"},{"key":"5779_CR3","doi-asserted-by":"publisher","first-page":"147937","DOI":"10.1016\/j.brainres.2022.147937","volume":"1788","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Gan L, Ren L, Lin Y, Ma C, Lin X (2022 Aug) Factors influencing the blood-brain barrier permeability. Brain Res 1788:147937. https:\/\/doi.org\/10.1016\/j.brainres.2022.147937","journal-title":"Brain Res"},{"key":"5779_CR4","doi-asserted-by":"publisher","first-page":"679425","DOI":"10.3389\/fimmu.2021.679425","volume":"12","author":"A Ghouzlani","year":"2021","unstructured":"Ghouzlani A, Kandoussi S, Tall M, Reddy KP, Rafii S, Badou A (2021) Immune checkpoint inhibitors in human glioma microenvironment. Front. Immunol 12:679425. https:\/\/doi.org\/10.3389\/fimmu.2021.679425","journal-title":"Front. Immunol"},{"issue":"1","key":"5779_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11060-014-1362-0","volume":"117","author":"CE Champ","year":"2014","unstructured":"Champ CE, Palmer JD, Volek JS, Werner-Wasik M, Andrews DW, Evans JJ, Glass J, Kim L, Shi W (2014 Mar) Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme. J Neurooncol 117(1):125\u2013131. https:\/\/doi.org\/10.1007\/s11060-014-1362-0","journal-title":"J Neurooncol"},{"issue":"5","key":"5779_CR6","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/s41591-019-0423-5","volume":"25","author":"Z Wang","year":"2019","unstructured":"Wang Z, Yip LY, Lee JHJ, Wu Z, Chew HY, Chong PKW, Teo CC, Ang HY-K, Peh KLE, Yuan J, Ma S, Choo LSK, Basri N, Jiang X, Yu Q, Hillmer AM, Lim WT, Lim TKH, Takano A, Tan EH, Tan DSW, Ho YS, Lim B, Tam WL (2019 May) Methionine is a metabolic dependency of tumor-initiating cells. Nat Med 25(5):825\u2013837. https:\/\/doi.org\/10.1038\/s41591-019-0423-5","journal-title":"Nat Med"},{"key":"5779_CR7","doi-asserted-by":"publisher","unstructured":"Lakomy R, Kazda T, Selingerova I, Poprach A, Pospisil P, Belanova R, Fadrus P, Vybihal V, Smrcka M, Jancalek R, Hynkova L, Muckova K, Hendrych M, Sana J, Slaby O, Slampa P (2020 Jul) Real-world evidence in Glioblastoma: Stupp\u2019s regimen after a decade. Front Oncol 10. https:\/\/doi.org\/10.3389\/fonc.2020.00840","DOI":"10.3389\/fonc.2020.00840"},{"key":"5779_CR8","doi-asserted-by":"publisher","unstructured":"Abdelwahab MG, Fenton KE, Preul MC, Rho JM, Lynch A, Stafford P, Scheck AC (2012) The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma. PLoS One 7(5):e36197. https:\/\/doi.org\/10.1371\/journal.pone.0036197","DOI":"10.1371\/journal.pone.0036197"},{"issue":"16","key":"5779_CR9","doi-asserted-by":"publisher","first-page":"5622","DOI":"10.1158\/1078-0432.CCR-04-0308","volume":"10","author":"P Mukherjee","year":"2004","unstructured":"Mukherjee P, Abate LE, Seyfried TN (2004) Antiangiogenic and proapoptotic effects of dietary restriction on experimental mouse and human brain tumors. Clin Cancer Res 10(16):5622\u20135629. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-0308","journal-title":"Clin Cancer Res"},{"issue":"1","key":"5779_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/1471-2407-11-315","volume":"11","author":"GD Maurer","year":"2011","unstructured":"Maurer GD, Brucker DP, B\u00e4hr O, Harter PN, Hattingen E, Walenta S, Mueller-Klieser W, Steinbach JP, Rieger J (2011) Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy. BMC Cancer 11(1):315. https:\/\/doi.org\/10.1186\/1471-2407-11-315","journal-title":"BMC Cancer"},{"issue":"1","key":"5779_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1743-7075-4-5","volume":"4","author":"W Zhou","year":"2007","unstructured":"Zhou W, Mukherjee P, Kiebish MA, Markis WT, Mantis JG, Seyfried TN (2007) The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer. Nutr Metab (Lond) 4(1):5. https:\/\/doi.org\/10.1186\/1743-7075-4-5","journal-title":"Nutr Metab (Lond)"},{"issue":"1","key":"5779_CR12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1743-7075-7-74","volume":"7","author":"P Stafford","year":"2010","unstructured":"Stafford P, Abdelwahab MG, Kim DY, Preul MC, Rho JM, Scheck AC (2010) The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma. Nutr Metab (Lond) 7(1):74. https:\/\/doi.org\/10.1186\/1743-7075-7-74","journal-title":"Nutr Metab (Lond)"},{"key":"5779_CR13","doi-asserted-by":"publisher","unstructured":"Javier R, Wang W, Drumm M, McCortney K, Sarkaria JN, Horbinski C (2022) The efficacy of an unrestricted cycling ketogenic diet in preclinical models of IDH wild-type and IDH mutant glioma. PLoS One 17(2):e0257725. https:\/\/doi.org\/10.1371\/journal.pone.0257725","DOI":"10.1371\/journal.pone.0257725"},{"issue":"1","key":"5779_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s42003-019-0455-x","volume":"2","author":"P Mukherjee","year":"2019","unstructured":"Mukherjee P, Augur ZM, Li M, Hill C, Greenwood B, Domin MA, Kondakci G, Narain NR, Kiebish MA, Bronson RT, Arismendi-Morillo G, Chinopoulos C, Seyfried TN (2019) Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma. Commun Biol 2(1):200. https:\/\/doi.org\/10.1038\/s42003-019-0455-x","journal-title":"Commun Biol"},{"issue":"11\u201312","key":"5779_CR15","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1080\/01635581.2020.1822423","volume":"73","author":"E Ciusani","year":"2021","unstructured":"Ciusani E, Vasco C, Rizzo A, Girgenti V, Padelli F, Pellegatta S, Fariselli L, Bruzzone MG, Salmaggi A (2021) MR-Spectroscopy and survival in mice with high grade glioma undergoing unrestricted ketogenic diet. Nutr Cancer 73(11\u201312):2315\u20132322. https:\/\/doi.org\/10.1080\/01635581.2020.1822423","journal-title":"Nutr Cancer"},{"key":"5779_CR16","doi-asserted-by":"publisher","unstructured":"Woolf EC, Curley KL, Liu Q, Turner GH, Charlton JA, Preul MC, Scheck AC (2015) The ketogenic diet alters the hypoxic response and affects expression of proteins associated with angiogenesis, invasive potential and vascular permeability in a mouse glioma Model. PLoS One 10(6):e0130357. https:\/\/doi.org\/10.1371\/journal.pone.0130357","DOI":"10.1371\/journal.pone.0130357"},{"key":"5779_CR17","doi-asserted-by":"publisher","unstructured":"Maeyama M, Tanaka K, Nishihara M, Irino Y, Shinohara M, Nagashima H, Tanaka H, Nakamizo S, Hashiguchi M, Fujita Y, Kohta M, Kohmura E, Sasayama T (2021) Metabolic changes and anti-tumor effects of a ketogenic diet combined with anti-angiogenic therapy in a glioblastoma mouse model. Sci Rep 11(1). https:\/\/doi.org\/10.1038\/s41598-020-79465-x","DOI":"10.1038\/s41598-020-79465-x"},{"issue":"22","key":"5779_CR18","doi-asserted-by":"publisher","first-page":"5550","DOI":"10.3390\/cancers14225550","volume":"14","author":"P Kesarwani","year":"2022","unstructured":"Kesarwani P, Kant S, Zhao Y, Miller CR, Chinnaiyan P (2022) The influence of the ketogenic diet on the immune tolerant microenvironment in Glioblastoma. Cancers (Basel) 14(22):5550. https:\/\/doi.org\/10.3390\/cancers14225550","journal-title":"Cancers (Basel)"},{"key":"5779_CR19","doi-asserted-by":"publisher","unstructured":"Rosito M, Maqbool J, Reccagni A, Mangano M, D\u2019andrea T, Rinaldi A, Peruzzi G, Silvestri B, Rosa A, Trettel F, D\u2019alessandro G, Catalano M, Fucile S, Limatola C (2025) Ketogenic diet induces an inflammatory reactive astrocytes phenotype reducing glioma growth. Cell Mol Life Sci 82(1). https:\/\/doi.org\/10.1007\/s00018-025-05600-4","DOI":"10.1007\/s00018-025-05600-4"},{"key":"5779_CR20","doi-asserted-by":"publisher","unstructured":"Sarkar S, Ashokan A, Surnar B, Banik B, Eichberg DG, Lepore S, Ficaro L, Slepak TI, Komotar RJ, Jones DR, Bilbao DC, Beurel E, Ivan ME, Dhar S (2026) Low carbohydrate high fat diet curbs glioblastoma by shifting lipids and limiting cancer stem cell metabolic flexibility. Commun Biol. https:\/\/doi.org\/10.1038\/s42003-026-10516-1","DOI":"10.1038\/s42003-026-10516-1"},{"issue":"6","key":"5779_CR21","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.3892\/ijo.2014.2382","volume":"44","author":"J Rieger","year":"2014","unstructured":"Rieger J, B\u00e4hr O, Maurer GD, Hattingen E, Franz K, Brucker D, Walenta S, K\u00e4mmerer U, Coy JF, Weller M, Steinbach JP (2014) ERGO: a pilot study of ketogenic diet in recurrent glioblastoma. Int J Oncol 44(6):1843\u20131852. https:\/\/doi.org\/10.3892\/ijo.2014.2382","journal-title":"Int J Oncol"},{"key":"5779_CR22","doi-asserted-by":"publisher","first-page":"149418","DOI":"10.1016\/j.bbrc.2023.149418","volume":"695","author":"Y Kubota","year":"2024","unstructured":"Kubota Y, Aoki Y, Masaki N, Obara K, Hamada K, Han Q, Bouvet M, Tsunoda T, Hoffman RM (2024) Methionine restriction of glioma does not induce MGMT and greatly improves temozolomide efficacy in an orthotopic nude-mouse model: a potential curable approach to a clinically-incurable disease. Biochem Bioph Res Co 695:149418. https:\/\/doi.org\/10.1016\/j.bbrc.2023.149418","journal-title":"Biochem Bioph Res Co"},{"issue":"6","key":"5779_CR23","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/cam4.1086","volume":"6","author":"F Gay","year":"2017","unstructured":"Gay F, Aguera K, S\u00e9n\u00e9chal K, Tainturier A, Berlier W, Maucort-Boulch D, Honnorat J, Horand F, Godfrin Y, Bourgeaux V (2017) Methionine tumor starvation by erythrocyte-encapsulated methionine gamma-lyase activity controlled with per os vitamin B6. Cancer Med 6(6):1437\u20131452. https:\/\/doi.org\/10.1002\/cam4.1086","journal-title":"Cancer Med"},{"issue":"1","key":"5779_CR24","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/s41467-023-36630-w","volume":"14","author":"PS Upadhyayula","year":"2023","unstructured":"Upadhyayula PS, Higgins DM, Mela A, Banu M, Dovas A, Zandkarimi F, Patel P, Mahajan A, Humala N, Nguyen TTT, Chaudhary KR, Liao L, Argenziano M, Sudhakar T, Sperring CP, Shapiro BL, Ahmed ER, Kinslow C, Ye LF, Siegelin MD, Cheng S, Soni R, Bruce JN, Stockwell BR, Canoll P (2023) Dietary restriction of cysteine and methionine sensitizes gliomas to ferroptosis and induces alterations in energetic metabolism. Nat Commun 14(1):1187. https:\/\/doi.org\/10.1038\/s41467-023-36630-w","journal-title":"Nat Commun"},{"issue":"5","key":"5779_CR25","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s43018-022-00348-3","volume":"3","author":"BJ Golbourn","year":"2022","unstructured":"Golbourn BJ, Halbert ME, Halligan K, Varadharajan S, Krug B, Mbah NE, Kabir N, Stanton A-CJ, Locke AL, Casillo SM, Zhao Y, Sanders LM, Cheney A, Mullett SJ, Chen A, Wassell M, Andren A, Perez J, Jane EP, Premkumar DRD, Koncar RF, Mirhadi S, McCarl LH, Chang Y-F, Wu YL, Gatesman TA, Cruz AF, Zapotocky M, Hu B, Kohanbash G, Wang X, Vartanian A, Moran MF, Lieberman F, Amankulor NM, Wendell SG, Vaske OM, Panigrahy A, Felker J, Bertrand KC et al. (2022) Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome. Nat Cancer 3(5):629\u2013648. https:\/\/doi.org\/10.1038\/s43018-022-00348-3","journal-title":"Nat Cancer"},{"issue":"1","key":"5779_CR26","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41698-024-00763-y","volume":"8","author":"J Li","year":"2024","unstructured":"Li J, Liu R, Hu H, Huang Y, Shi Y, Li H, Chen H, Cai M, Wang N, Yan T, Wang K, Liu H (2024) Methionine deprivation inhibits glioma proliferation and EMT via the TP53TG1\/miR-96-5p\/STK17B ceRNA pathway. Npj Precis Onc 8(1):270. https:\/\/doi.org\/10.1038\/s41698-024-00763-y","journal-title":"Npj Precis Onc"},{"issue":"10","key":"5779_CR27","first-page":"4017","volume":"61","author":"DM Kokkinakis","year":"2001","unstructured":"Kokkinakis DM, Hoffman RM, Frenkel EP, Wick JB, Han Q, Xu M, Tan Y, Schold SC (2001) Synergy between methionine stress and chemotherapy in the treatment of brain tumor xenografts in athymic mice. Cancer Res 61(10):4017\u20134023","journal-title":"Cancer Res"},{"issue":"2","key":"5779_CR28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.toxlet.2014.11.011","volume":"232","author":"H Liu","year":"2015","unstructured":"Liu H, Zhang W, Wang K, Wang X, Yin F, Li C, Wang C, Zhao B, Zhong C, Zhang J, Peng F, Bi Y, Shen C, Hou X, Zhang D, Liu Y, Ai J, Zhao S (2015) Methionine and cystine double deprivation stress suppresses glioma proliferation via inducing ROS\/autophagy. Toxicol Lett 232(2):349\u2013355. https:\/\/doi.org\/10.1016\/j.toxlet.2014.11.011","journal-title":"Toxicol Lett"},{"key":"5779_CR29","first-page":"5004","volume":"12","author":"F Qian","year":"2022","unstructured":"Qian F (2022) Methionine deprivation inhibits glioma growth through downregulation of CTSL. Am J Cancer Res 12:5004\u20135018","journal-title":"Am J Cancer Res"},{"key":"5779_CR30","doi-asserted-by":"publisher","unstructured":"Lozzi B, Gatesman TA, Dasgupta P, Sardar D, Ko Y, Mao C, Chen H-C, Curry RN, Choi D, Mohila CA, Bondy ML, Rao G, Gallo M, Agnihotri S, Deneen B (2026) Hp1bp3 loss links chromatin reorganization to metabolic vulnerability in glioma. Proc Natl Acad Sci USA 123(24). https:\/\/doi.org\/10.1073\/pnas.2601061123","DOI":"10.1073\/pnas.2601061123"},{"key":"5779_CR31","doi-asserted-by":"publisher","unstructured":"Santos J, Da Cruz WM, Sch\u00ef\u00bf\u00bdnthal A, Salazar M, Fontes CA, Quirico\u2011Santos T, Da Fonseca C (2017) Efficacy of a ketogenic diet with concomitant intranasal perillyl alcohol as a novel strategy for the therapy of recurrent glioblastoma. Oncol Lett. https:\/\/doi.org\/10.3892\/ol.2017.7362","DOI":"10.3892\/ol.2017.7362"},{"key":"5779_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/4496734","volume":"2022","author":"MCL Phillips","year":"2022","unstructured":"Phillips MCL, Leyden J, McManus EJ, Lowyim DG, Ziad F, Moon BG, Haji Mohd Yasin NAB, Tan A, Thotathil Z, Jameson MB (2022) Feasibility and safety of a combined metabolic strategy in glioblastoma multiforme: a prospective case series. J Oncol 2022:1\u201310. https:\/\/doi.org\/10.1155\/2022\/4496734","journal-title":"J Oncol"},{"issue":"4","key":"5779_CR33","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1080\/01635581.2018.1460677","volume":"70","author":"KJ Martin-McGill","year":"2018","unstructured":"Martin-McGill KJ, Marson AG, Smith CT, Jenkinson MD (2018) The modified ketogenic diet in adults with glioblastoma: an evaluation of feasibility and deliverability within the National health Service. Nutr Cancer 70(4):643\u2013649. https:\/\/doi.org\/10.1080\/01635581.2018.1460677","journal-title":"Nutr Cancer"},{"key":"5779_CR34","doi-asserted-by":"publisher","unstructured":"van der Louw EJTM, Olieman JF, Catsman-Berrevoets CE, Vincent AJPE (2019) Author response to \u2018problems associated with a highly artificial ketogenic diet: letter to the Editor Re: van der Louw EJTM, Olieman JF, van den bemt PMLA, et al. \u201cKetogenic diet treatment as adjuvant to standard treatment of glioblastoma multiforme: a feasibility and safety study\u201d\u2019. Ther Adv Med Oncol 11. https:\/\/doi.org\/10.1177\/1758835919882584","DOI":"10.1177\/1758835919882584"},{"issue":"1","key":"5779_CR35","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11060-020-03417-8","volume":"147","author":"KJ Martin-McGill","year":"2020","unstructured":"Martin-McGill KJ, Marson AG, Tudur Smith C, Young B, Mills SJ, Cherry MG, Jenkinson MD (2020) Ketogenic diets as an adjuvant therapy for glioblastoma (KEATING): a randomized, mixed methods, feasibility study. J Neurooncol 147(1):213\u2013227. https:\/\/doi.org\/10.1007\/s11060-020-03417-8","journal-title":"J Neurooncol"},{"issue":"1","key":"5779_CR36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40170-020-00230-9","volume":"8","author":"P Klein","year":"2020","unstructured":"Klein P, Tyrlikova I, Zuccoli G, Tyrlik A, Maroon JC (2020) Treatment of glioblastoma multiforme with \u201cclassic\u201d 4: 1 ketogenic diet total meal replacement. Cancer Metab 8(1):24. https:\/\/doi.org\/10.1186\/s40170-020-00230-9","journal-title":"Cancer Metab"},{"key":"5779_CR37","doi-asserted-by":"publisher","unstructured":"Schreck KC, Hsu F-C, Berrington A, Henry-Barron B, Vizthum D, Blair L, Kossoff EH, Easter L, Whitlow CT, Barker PB, Cervenka MC, Blakeley JO, Strowd RE (2021) Feasibility and biological activity of a Ketogenic\/Intermittent-fasting diet in patients with glioma. Neurology 97(9). https:\/\/doi.org\/10.1212\/WNL.0000000000012386","DOI":"10.1212\/WNL.0000000000012386"},{"issue":"3","key":"5779_CR38","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s11060-021-03786-8","volume":"153","author":"K Porper","year":"2021","unstructured":"Porper K, Shpatz Y, Plotkin L, Pechthold RG, Talianski A, Champ CE, Furman O, Shimoni-Sebag A, Symon Z, Amit U, Hemi R, Kanety H, Mardor Y, Cohen ZR, Jan E, Genssin H, Anikster Y, Zach L, Lawrence YR (2021) A phase I clinical trial of dose-escalated metabolic therapy combined with concomitant radiation therapy in high-grade glioma. J Neurooncol 153(3):487\u2013496. https:\/\/doi.org\/10.1007\/s11060-021-03786-8","journal-title":"J Neurooncol"},{"key":"5779_CR39","doi-asserted-by":"publisher","unstructured":"Schwartz KA, Noel M, Nikolai M, Olson LK, Hord NG, Zakem M, Clark J, Elnabtity M, Figueroa B, Chang HT (2022) Long term survivals in aggressive primary brain malignancies treated with an adjuvant ketogenic diet. Front Nutr 9. https:\/\/doi.org\/10.3389\/fnut.2022.770796","DOI":"10.3389\/fnut.2022.770796"},{"issue":"6","key":"5779_CR40","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1080\/01635581.2020.1779759","volume":"73","author":"A Foppiani","year":"2021","unstructured":"Foppiani A, De Amicis R, Lessa C, Leone A, Ravella S, Ciusani E, Silvani A, Zuccoli G, Battezzati A, Lamperti E, Bertoli S (2021) Isocaloric ketogenic diet in adults with high-grade gliomas: a prospective metabolic study. Nutr Cancer 73(6):1004\u20131014. https:\/\/doi.org\/10.1080\/01635581.2020.1779759","journal-title":"Nutr Cancer"},{"key":"5779_CR41","doi-asserted-by":"publisher","unstructured":"Amaral LJ, Gresham G, Kim S, Tighiouart M, Nelson TA, Welborn A, Lockshon L, Noorvash B, Rudnick JD, Irwin SA, Freedland SJ, Hu J (2025) A phase 1 safety and feasibility trial of a ketogenic diet plus standard of care for patients with recently diagnosed glioblastoma. Sci Rep 15(1). https:\/\/doi.org\/10.1038\/s41598-025-06675-6","DOI":"10.1038\/s41598-025-06675-6"},{"key":"5779_CR42","doi-asserted-by":"publisher","unstructured":"Kiryttopoulos A, Evangeliou AE, Katsanika I, Boukovinas I, Foroglou N, Zountsas B, Cheva A, Nikolopoulos V, Zaramboukas T, Duraj T, Seyfried TN, Spilioti M (2025) Successful application of dietary ketogenic metabolic therapy in patients with glioblastoma: a clinical study. Front Nutr 11. https:\/\/doi.org\/10.3389\/fnut.2024.1489812","DOI":"10.3389\/fnut.2024.1489812"},{"key":"5779_CR43","doi-asserted-by":"publisher","unstructured":"Phillips MCL, Thotathil Z, Haji Mohd Yasin NAB, de Groot C, Tan A, Kuper-Hommel M, Creagh L-A, Ji E, Naidoo N, van Essen M, Ziad F, Moon BG, Frampton C, Jameson MB (2026) Intensive multimodal ketogenic metabolic therapy in glioblastoma: a clinical trial. Neuro-Oncol Adv 8(1). https:\/\/doi.org\/10.1093\/noajnl\/vdag165","DOI":"10.1093\/noajnl\/vdag165"},{"issue":"1","key":"5779_CR44","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00394-021-02666-1","volume":"61","author":"M Voss","year":"2022","unstructured":"Voss M, Wenger KJ, von Mettenheim N, Bojunga J, Vetter M, Diehl B, Franz K, Gerlach R, Ronellenfitsch MW, Harter PN, Hattingen E, Steinbach JP, R\u00f6del C, Rieger J (2022) Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial. Eur J Nutr 61(1):477\u2013487. https:\/\/doi.org\/10.1007\/s00394-021-02666-1","journal-title":"Eur J Nutr"},{"issue":"1","key":"5779_CR45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/01635580701525877","volume":"60","author":"X Durando","year":"2007","unstructured":"Durando X, Thivat E, Farges M-C, Cellarier E, D\u2019Incan M, Demidem A, Vasson M-P, Barthomeuf C, Chollet P (2007) Optimal methionine-free diet duration for nitrourea treatment: a phase I clinical trial. Nutr Cancer 60(1):23\u201330. https:\/\/doi.org\/10.1080\/01635580701525877","journal-title":"Nutr Cancer"},{"issue":"12","key":"5779_CR46","first-page":"5235","volume":"29","author":"E Thivat","year":"2009","unstructured":"Thivat E (2009) Phase II trial of the association of a methionine-free diet with cystemustine therapy in melanoma and glioma. Anticancer Res 29(12):5235\u20135240","journal-title":"Anticancer Res"},{"issue":"4","key":"5779_CR47","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.ijrobp.2020.06.021","volume":"108","author":"M Voss","year":"2020","unstructured":"Voss M, Wagner M, von Mettenheim N, Harter PN, Wenger KJ, Franz K, Bojunga J, Vetter M, Gerlach R, Glatzel M, Paulsen F, Hattingen E, Baehr O, Ronellenfitsch MW, Fokas E, Imhoff D, Steinbach JP, R\u00f6del C, Rieger J (2020 Nov) ERGO2: a prospective, randomized trial of calorie-restricted ketogenic diet and fasting in addition to reirradiation for malignant glioma. Int J Radiat Oncol*Biol*Phys 108(4):987\u2013995. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.06.021","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"issue":"10","key":"5779_CR48","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1194\/jlr.R046292","volume":"55","author":"RL Veech","year":"2014","unstructured":"Veech RL (2014) Ketone ester effects on metabolism and transcription. J Lipid Res 55(10):2004\u20132006. https:\/\/doi.org\/10.1194\/jlr.R046292","journal-title":"J Lipid Res"},{"issue":"1","key":"5779_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1528-1167.2007.00914.x","volume":"48","author":"AL Hartman","year":"2007","unstructured":"Hartman AL, Vining EPG (2007) Clinical aspects of the ketogenic diet. Epilepsia 48(1):31\u201342. https:\/\/doi.org\/10.1111\/j.1528-1167.2007.00914.x","journal-title":"Epilepsia"},{"issue":"1","key":"5779_CR50","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-nutr-071816-064916","volume":"37","author":"JC Newman","year":"2017","unstructured":"Newman JC, Verdin E (2017) \u03b2-hydroxybutyrate: a signaling metabolite. Annu Rev Nutr 37(1):51\u201376. https:\/\/doi.org\/10.1146\/annurev-nutr-071816-064916","journal-title":"Annu Rev Nutr"},{"issue":"2","key":"5779_CR51","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/bjc.1983.38","volume":"47","author":"MJ Tisdale","year":"1983","unstructured":"Tisdale MJ, Brennan RA (1983 Feb) Loss of acetoacetate coenzyme a transferase activity in tumours of peripheral tissues. Br J Cancer 47(2):293\u2013297. https:\/\/doi.org\/10.1038\/bjc.1983.38","journal-title":"Br J Cancer"},{"issue":"2","key":"5779_CR52","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s11060-020-03431-w","volume":"147","author":"FA Vallejo","year":"2020","unstructured":"Vallejo FA, Shah SS, de Cordoba N, Walters WM, Prince J, Khatib Z, Komotar RJ, Vanni S, Graham RM (2020 Apr) The contribution of ketone bodies to glycolytic inhibition for the treatment of adult and pediatric glioblastoma. J Neurooncol 147(2):317\u2013326. https:\/\/doi.org\/10.1007\/s11060-020-03431-w","journal-title":"J Neurooncol"},{"issue":"1","key":"5779_CR53","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1743-7075-10-47","volume":"10","author":"HT Chang","year":"2013","unstructured":"Chang HT, Olson L, Schwartz KA (2013) Ketolytic and glycolytic enzymatic expression profiles in malignant gliomas: implication for ketogenic diet therapy. Nutr Metab (Lond) 10(1):47. https:\/\/doi.org\/10.1186\/1743-7075-10-47","journal-title":"Nutr Metab (Lond)"},{"issue":"8","key":"5779_CR54","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1093\/neuonc\/now088","volume":"18","author":"HMD Feyter","year":"2016","unstructured":"Feyter HMD, Behar KL, Rao JU, Madden-Hennessey K, Ip KL, Hyder F, Drewes LR, Geschwind J-F, de Graaf RA, Rothman DL (2016 Aug) A ketogenic diet increases transport and oxidation of ketone bodies in RG2 and 9L gliomas without affecting tumor growth. Neuro Oncol 18(8):1079\u20131087. https:\/\/doi.org\/10.1093\/neuonc\/now088","journal-title":"Neuro Oncol"},{"issue":"2","key":"5779_CR55","first-page":"101","volume":"7","author":"MJ Tisdale","year":"1984","unstructured":"Tisdale MJ (1984 Jun) Role of acetoacetyl-CoA synthetase in acetoacetate utilization by tumor cells. Cancer Biochem Biophys 7(2):101\u2013107","journal-title":"Cancer Biochem Biophys"},{"key":"5779_CR56","doi-asserted-by":"publisher","unstructured":"Malinowska D, \u017bendzian-Piotrowska M (2024 Jan) Ketogenic Diet: a review of composition diversity, mechanism of action and clinical application. J Nutr Metab 2024(1). https:\/\/doi.org\/10.1155\/2024\/6666171","DOI":"10.1155\/2024\/6666171"},{"issue":"4","key":"5779_CR57","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/1028415X.2019.1627769","volume":"24","author":"M Barzegar","year":"2021","unstructured":"Barzegar M, Afghan M, Tarmahi V, Behtari M, Khamaneh SR, Raeisi S (2021 Apr) Ketogenic diet: overview, types, and possible anti-seizure mechanisms. Nutritional Neurosci 24(4):307\u2013316. https:\/\/doi.org\/10.1080\/1028415X.2019.1627769","journal-title":"Nutritional Neurosci"},{"key":"5779_CR58","doi-asserted-by":"publisher","unstructured":"van der Louw EJTM, Olieman JF, Catsman-Berrevoets CE, Vincent AJPE (2019 Jan) Author response to \u2018problems associated with a highly artificial ketogenic diet: letter to the Editor Re: van der Louw EJTM, Olieman JF, van den bemt PMLA, et al. \u201cKetogenic diet treatment as adjuvant to standard treatment of glioblastoma multiforme: a feasibility and safety study\u201d\u2019. Ther Adv Med Oncol 11. https:\/\/doi.org\/10.1177\/1758835919882584","DOI":"10.1177\/1758835919882584"},{"key":"5779_CR59","doi-asserted-by":"publisher","unstructured":"Hasek BE, Stewart LK, Henagan TM, Boudreau A, Lenard NR, Black C, Shin J, Huypens P, Malloy VL, Plaisance EP, Krajcik RA, Orentreich N, Gettys TW (2010 Sep) Dietary methionine restriction enhances metabolic flexibility and increases uncoupled respiration in both fed and fasted states. Am J Physiol-Regul, Intgr Comp Physiol 299(3):R728\u2013R739. https:\/\/doi.org\/10.1152\/ajpregu.00837.2009","DOI":"10.1152\/ajpregu.00837.2009"},{"key":"5779_CR60","doi-asserted-by":"publisher","unstructured":"Schreck KC, Hsu F-C, Berrington A, Henry-Barron B, Vizthum D, Blair L, Kossoff EH, Easter L, Whitlow CT, Barker PB, Cervenka MC, Blakeley JO, Strowd RE (2021 Aug) Feasibility and biological activity of a Ketogenic\/Intermittent-fasting diet in patients with glioma. Neurology 97(9). https:\/\/doi.org\/10.1212\/WNL.0000000000012386","DOI":"10.1212\/WNL.0000000000012386"},{"key":"5779_CR61","doi-asserted-by":"publisher","unstructured":"Schwartz KA, Noel M, Nikolai M, Olson LK, Hord NG, Zakem M, Clark J, Elnabtity M, Figueroa B, Chang HT (2022 May) Long term survivals in aggressive primary brain malignancies treated with an adjuvant ketogenic diet. Front Nutr 9. https:\/\/doi.org\/10.3389\/fnut.2022.770796","DOI":"10.3389\/fnut.2022.770796"},{"key":"5779_CR62","doi-asserted-by":"publisher","unstructured":"Sasayama T, Tanaka K, Nagashima H, Takahashi M, Yamanishi M, Kuroda M, Tabuchi S, Hagihara K, Yamanishi S, Ikeuchi Y, Fujita Y, Iwahashi H, Hotta S, Matsunaga M, Sanada S, Muragaki Y, Nishihara M (2026) Ketogenic diet therapy for high-grade gliomas combined with standard treatment using an angiogenesis inhibitor: an exploratory pilot study on feasibility. Neuro-Oncol Adv 8(1). https:\/\/doi.org\/10.1093\/noajnl\/vdaf264","DOI":"10.1093\/noajnl\/vdaf264"},{"issue":"18","key":"5779_CR63","first-page":"4899","volume":"54","author":"T Fiskerstrand","year":"1994","unstructured":"Fiskerstrand T, Christensen B, Tysnes OB, Ueland PM, Refsum H (1994) Development and reversion of methionine dependence in a human glioma cell line: relation to homocysteine remethylation and cobalamin status. Cancer Res 54(18):4899\u20134906","journal-title":"Cancer Res"},{"issue":"2","key":"5779_CR64","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/PL00000852","volume":"58","author":"T Thomas","year":"2001","unstructured":"Thomas T, Thomas TJ (2001 Feb) Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. CMLS, Cell Mol Life Sci 58(2):244\u2013258. https:\/\/doi.org\/10.1007\/PL00000852","journal-title":"CMLS, Cell Mol Life Sci"},{"issue":"8","key":"5779_CR65","first-page":"3103","volume":"29","author":"N Najim","year":"2009","unstructured":"Najim N, Podmore ID, McGown A, Estlin EJ (2009 Aug) Methionine restriction reduces the chemosensitivity of central nervous system tumour cell lines. Anticancer Res 29(8):3103\u20133108","journal-title":"Anticancer Res"},{"issue":"11","key":"5779_CR66","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1074\/mcp.RA117.000154","volume":"16","author":"K Zhang","year":"2017","unstructured":"Zhang K, Xu P, Sowers JL, Machuca DF, Mirfattah B, Herring J, Tang H, Chen Y, Tian B, Brasier AR, Sowers LC (2017 Nov) Proteome analysis of hypoxic Glioblastoma cells reveals sequential metabolic adaptation of one-carbon metabolic pathways. Mol Cellular Proteomics 16(11):1906\u20131921. https:\/\/doi.org\/10.1074\/mcp.RA117.000154","journal-title":"Mol Cellular Proteomics"},{"issue":"13","key":"5779_CR67","doi-asserted-by":"publisher","first-page":"7156","DOI":"10.3390\/ijms23137156","volume":"23","author":"ML Sowers","year":"2022","unstructured":"Sowers ML, Sowers LC (2022 Jun) Glioblastoma and methionine addiction. IJMS 23(13):7156. https:\/\/doi.org\/10.3390\/ijms23137156","journal-title":"IJMS"},{"issue":"10","key":"5779_CR68","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1111\/cas.15001","volume":"112","author":"S Yamaguchi","year":"2021","unstructured":"Yamaguchi S, Hirata K, Okamoto M, Shimosegawa E, Hatazawa J, Hirayama R, Kagawa N, Kishima H, Oriuchi N, Fujii M, Kobayashi K, Kobayashi H, Terasaka S, Nishijima K-I, Kuge Y, Ito YM, Nishihara H, Tamaki N, Shiga T (2021 Oct) Determination of brain tumor recurrence using 11 C-methionine positron emission tomography after radiotherapy. Cancer Sci 112(10):4246\u20134256. https:\/\/doi.org\/10.1111\/cas.15001","journal-title":"Cancer Sci"},{"issue":"1","key":"5779_CR69","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41598-021-04216-5","volume":"12","author":"K Nakajo","year":"2022","unstructured":"Nakajo K, Uda T, Kawashima T, Terakawa Y, Ishibashi K, Tsuyuguchi N, Tanoue Y, Nagahama A, Uda H, Koh S, Sasaki T, Ohata K, Kanemura Y, Goto T (2022 Jan) Maximum 11C-methionine PET uptake as a prognostic imaging biomarker for newly diagnosed and untreated astrocytic glioma. Sci Rep 12(1):546. https:\/\/doi.org\/10.1038\/s41598-021-04216-5","journal-title":"Sci Rep"},{"issue":"18","key":"5779_CR70","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.1113\/JP283552","volume":"600","author":"S Jani","year":"2022","unstructured":"Jani S, Eira DD, Stefanovic M, Ceddia RB (2022 Sep) The ketogenic diet prevents steatosis and insulin resistance by reducing lipogenesis, diacylglycerol accumulation and protein kinase C activity in male rat liver. J Physiol 600(18):4137\u20134151. https:\/\/doi.org\/10.1113\/JP283552","journal-title":"J Physiol"},{"key":"5779_CR71","doi-asserted-by":"publisher","unstructured":"Elango R (2020 Oct) Methionine nutrition and metabolism: insights from animal studies to inform human nutrition. J Nutr 150:2518S\u20132523S. https:\/\/doi.org\/10.1093\/jn\/nxaa155","DOI":"10.1093\/jn\/nxaa155"},{"issue":"2","key":"5779_CR72","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.tem.2023.10.001","volume":"35","author":"A Paoli","year":"2024","unstructured":"Paoli A, Tinsley GM, Mattson MP, Vivo ID, Dhawan R, Moro T (2024 Feb) Common and divergent molecular mechanisms of fasting and ketogenic diets. Trends Endocrinol Metab 35(2):125\u2013141. https:\/\/doi.org\/10.1016\/j.tem.2023.10.001","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"5779_CR73","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1096\/fj.14-249458","volume":"28","author":"S Ghosh","year":"2014","unstructured":"Ghosh S, Wanders D, Stone KP, Van NT, Cortez CC, Gettys TW (2014 Jun) A systems biology analysis of the unique and overlapping transcriptional responses to caloric restriction and dietary methionine restriction in rats. Faseb J 28(6):2577\u20132590. https:\/\/doi.org\/10.1096\/fj.14-249458","journal-title":"Faseb J"},{"issue":"26","key":"5779_CR74","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1056\/NEJMra1905136","volume":"381","author":"R de Cabo","year":"2019","unstructured":"de Cabo R, Mattson MP (2019 Dec) Effects of intermittent fasting on health, aging, and disease. N Engl J Med 381(26):2541\u20132551. https:\/\/doi.org\/10.1056\/NEJMra1905136","journal-title":"N Engl J Med"},{"key":"5779_CR75","doi-asserted-by":"publisher","first-page":"101500","DOI":"10.1016\/j.arr.2021.101500","volume":"72","author":"U Navik","year":"2021","unstructured":"Navik U, Sheth VG, Khurana A, Jawalekar SS, Allawadhi P, Gaddam RR, Bhatti JS, Tikoo K (2021 Dec) Methionine as a double-edged sword in health and disease: current perspective and future challenges. Ageing Res Rev 72:101500. https:\/\/doi.org\/10.1016\/j.arr.2021.101500","journal-title":"Ageing Res Rev"},{"issue":"2","key":"5779_CR76","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1542\/pir.2020-004275","volume":"43","author":"E Andrewski","year":"2022","unstructured":"Andrewski E, Cheng K, Vanderpool C (2022 Feb) Nutritional deficiencies in vegetarian, gluten-free, and ketogenic diets. Pediatr Rev 43(2):61\u201370. https:\/\/doi.org\/10.1542\/pir.2020-004275","journal-title":"Pediatr Rev"},{"issue":"9","key":"5779_CR77","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1470-2045(07)70274-7","volume":"8","author":"AM Groves","year":"2007","unstructured":"Groves AM, Win T, Haim SB, Ell PJ (2007 Sep) Non-[18F]FDG PET in clinical oncology. Lancet Oncol 8(9):822\u2013830. https:\/\/doi.org\/10.1016\/S1470-2045(07)70274-7","journal-title":"The Lancet Oncol"},{"issue":"1","key":"5779_CR78","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1146\/annurev-nutr-062320-111849","volume":"42","author":"H Fang","year":"2022","unstructured":"Fang H, Stone KP, Wanders D, Forney LA, Gettys TW (2022) The origins, evolution, and future of dietary methionine restriction. Annu Rev Nutr 42(1):201\u2013226. https:\/\/doi.org\/10.1146\/annurev-nutr-062320-111849","journal-title":"Annu Rev Nutr"},{"issue":"6","key":"5779_CR79","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg O, Wind F, Negelein E (1927 Mar) The metabolism of tumors in the body. J Gen Physiol 8(6):519\u2013530. https:\/\/doi.org\/10.1085\/jgp.8.6.519","journal-title":"J Gen Physiol"},{"issue":"7","key":"5779_CR80","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.cell.2014.11.025","volume":"159","author":"T Mashimo","year":"2014","unstructured":"Mashimo T, Pichumani K, Vemireddy V, Hatanpaa K, Singh D, Sirasanagandla S, Nannepaga S, Piccirillo S, Kovacs Z, Foong C, Huang Z, Barnett S, Mickey B, DeBerardinis R, Tu B, Maher E, Bachoo R (2014 Dec) Acetate is a Bioenergetic substrate for human Glioblastoma and brain metastases. Cell 159(7):1603\u20131614. https:\/\/doi.org\/10.1016\/j.cell.2014.11.025","journal-title":"Cell"},{"issue":"6","key":"5779_CR81","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.cmet.2012.05.001","volume":"15","author":"I Marin-Valencia","year":"2012","unstructured":"Marin-Valencia I, Yang C, Mashimo T, Cho S, Baek H, Yang X-L, Rajagopalan K, Maddie M, Vemireddy V, Zhao Z, Cai L, Good L, Tu B, Hatanpaa K, Mickey B, Mat\u00e9s J, Pascual J, Maher E, Malloy C, DeBerardinis R, Bachoo R (2012 Jun) Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo. Cell MetabCell Metab 15(6):827\u2013837. https:\/\/doi.org\/10.1016\/j.cmet.2012.05.001","journal-title":"Cell MetabCell Metab"},{"issue":"3","key":"5779_CR82","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cmet.2006.01.012","volume":"3","author":"I Papandreou","year":"2006","unstructured":"Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC (2006 Mar) HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell MetabCell Metab 3(3):187\u2013197. https:\/\/doi.org\/10.1016\/j.cmet.2006.01.012","journal-title":"Cell MetabCell Metab"},{"issue":"9","key":"5779_CR83","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nrc2468","volume":"8","author":"NC Denko","year":"2008","unstructured":"Denko NC (2008 Sep) Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer 8(9):705\u2013713. https:\/\/doi.org\/10.1038\/nrc2468","journal-title":"Nat Rev Cancer"},{"issue":"40","key":"5779_CR84","doi-asserted-by":"publisher","first-page":"33436","DOI":"10.1074\/jbc.M112.384578","volume":"287","author":"C Wanka","year":"2012","unstructured":"Wanka C, Steinbach JP, Rieger J (2012 Sep) Tp53-induced glycolysis and Apoptosis regulator (TIGAR) protects glioma cells from starvation-induced cell Death by up-regulating respiration and improving cellular redox homeostasis. J Biol ChemJournal Biol Chem 287(40):33436\u201333446. https:\/\/doi.org\/10.1074\/jbc.M112.384578","journal-title":"J Biol ChemJournal Biol Chem"},{"issue":"11","key":"5779_CR85","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1158\/0008-5472.CAN-03-2904","volume":"64","author":"RL Elstrom","year":"2004","unstructured":"Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, Plas DR, Zhuang H, Cinalli RM, Alavi A, Rudin CM, Thompson CB (2004 Jun) Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 64(11):3892\u20133899. https:\/\/doi.org\/10.1158\/0008-5472.CAN-03-2904","journal-title":"Cancer Res"},{"issue":"1","key":"5779_CR86","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.semcancer.2008.11.010","volume":"19","author":"RB Robey","year":"2009","unstructured":"Robey RB, Hay N (2009 Feb) Is akt the \u201cwarburg kinase\u201d?\u2014akt-energy metabolism interactions and oncogenesis. Semin Cancer Biol 19(1):25\u201331. https:\/\/doi.org\/10.1016\/j.semcancer.2008.11.010","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"5779_CR87","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/sj.bjc.6601269","volume":"89","author":"TN Seyfried","year":"2003","unstructured":"Seyfried TN, Sanderson TM, El-Abbadi MM, McGowan R, Mukherjee P (2003 Oct) Role of glucose and ketone bodies in the metabolic control of experimental brain cancer. Br J Cancer 89(7):1375\u20131382. https:\/\/doi.org\/10.1038\/sj.bjc.6601269","journal-title":"Br J Cancer"},{"key":"5779_CR88","doi-asserted-by":"publisher","unstructured":"Strickland M, Stoll EA (2017 Apr) Metabolic reprogramming in glioma. Front Cell Dev Biol 5. https:\/\/doi.org\/10.3389\/fcell.2017.00043","DOI":"10.3389\/fcell.2017.00043"},{"key":"5779_CR89","doi-asserted-by":"publisher","first-page":"218426","DOI":"10.1016\/j.canlet.2026.218426","volume":"646","author":"E Martell","year":"2026","unstructured":"Martell E, Kuzmychova H, Grewal A, Chawla U, Jain C, Anderson CM, Sharif T (2026 May) Exploiting metabolic dependencies for therapeutic targeting of brain cancers. Cancer Lett 646:218426. https:\/\/doi.org\/10.1016\/j.canlet.2026.218426","journal-title":"Cancer Lett"},{"issue":"14","key":"5779_CR90","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1212\/01.wnl.0000345668.03039.90","volume":"72","author":"PL Nghiemphu","year":"2009","unstructured":"Nghiemphu PL, Liu W, Lee Y, Than T, Graham C, Lai A, Green RM, Pope WB, Liau LM, Mischel PS, Nelson SF, Elashoff R, Cloughesy TF (2009 Apr) Bevacizumab and chemotherapy for recurrent glioblastoma. Neurology 72(14):1217\u20131222. https:\/\/doi.org\/10.1212\/01.wnl.0000345668.03039.90","journal-title":"Neurology"},{"issue":"6","key":"5779_CR91","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.eprac.2026.01.024","volume":"32","author":"LL Morikawa","year":"2026","unstructured":"Morikawa LL, Nery M, Toyoshima MTK (2026 Jun) Glucocorticoid-induced hyperglycemia in patients with cancer: mechanisms, clinical implications, and management strategies. Endocr Pract 32(6):990\u20131000. https:\/\/doi.org\/10.1016\/j.eprac.2026.01.024","journal-title":"Endocr Pract"},{"issue":"10","key":"5779_CR92","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1001\/jamaneurol.2014.1205","volume":"71","author":"Z Turkalp","year":"2014","unstructured":"Turkalp Z, Karamchandani J, Das S (2014 Oct) IDH mutation in glioma. JAMA Neurol 71(10):1319. https:\/\/doi.org\/10.1001\/jamaneurol.2014.1205","journal-title":"JAMA Neurol"},{"key":"5779_CR93","doi-asserted-by":"publisher","unstructured":"Gunn K, Losman J-A (2024 May) Isocitrate dehydrogenase mutations in cancer: mechanisms of transformation and metabolic liability. Cold Spring Harb Perspect Med 14(5):a041537. https:\/\/doi.org\/10.1101\/cshperspect.a041537","DOI":"10.1101\/cshperspect.a041537"},{"issue":"4","key":"5779_CR94","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/imm.13649","volume":"169","author":"F Tang","year":"2023","unstructured":"Tang F, Wang D-W, Xi C, Yang J-Z, Liu Z-Y, Yu D-H, Wang Z-F, Li Z-Q (2023 Aug) Local and systemic effects of IDH mutations on primary glioma patients. Immunology 169(4):503\u2013514. https:\/\/doi.org\/10.1111\/imm.13649","journal-title":"Immunology"},{"issue":"5","key":"5779_CR95","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1093\/neuonc\/not243","volume":"16","author":"C Chesnelong","year":"2014","unstructured":"Chesnelong C, Chaumeil MM, Blough MD, Al-Najjar M, Stechishin OD, Chan JA, Pieper RO, Ronen SM, Weiss S, Luchman HA, Cairncross JG (2014 May) Lactate dehydrogenase a silencing in IDH mutant gliomas. Neuro-Oncology 16(5):686\u2013695. https:\/\/doi.org\/10.1093\/neuonc\/not243","journal-title":"Neuro-Oncology"},{"issue":"30","key":"5779_CR96","doi-asserted-by":"publisher","first-page":"49165","DOI":"10.18632\/oncotarget.17106","volume":"8","author":"M Khurshed","year":"2017","unstructured":"Khurshed M, Molenaar RJ, Lenting K, Leenders WP, van Noorden CJF (2017 Jul) In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1 -mutated glioma. Oncotarget 8(30):49165\u201349177. https:\/\/doi.org\/10.18632\/oncotarget.17106","journal-title":"Oncotarget"},{"issue":"14","key":"5779_CR97","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.3390\/cancers18142298","volume":"18","author":"N Imai","year":"2026","unstructured":"Imai N, Yano H, Ikegame Y, Yasuda S, Morishima R, Kumagai Y, Ikuta S, Maruyama T, Ohe N, Kumagai M, Muragaki Y, Shinoda J, Izumo T (2026 Jul) Glucose hypometabolic pattern and prediction of isocitrate dehydrogenase status in non-contrast-enhanced glioma using Z-Score-based 18F-Fluorodeoxyglucose positron emission tomography. Cancers (Basel) 18(14):2298. https:\/\/doi.org\/10.3390\/cancers18142298","journal-title":"Cancers (Basel)"},{"issue":"7","key":"5779_CR98","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1056\/NEJMoa2304194","volume":"389","author":"IK Mellinghoff","year":"2023","unstructured":"Mellinghoff IK, van den Bent MJ, Blumenthal DT, Touat M, Peters KB, Clarke J, Mendez J, Yust-Katz S, Welsh L, Mason WP, Ducray F, Umemura Y, Nabors B, Holdhoff M, Hottinger AF, Arakawa Y, Sepulveda JM, Wick W, Soffietti R, Perry JR, Giglio P, de la Fuente M, Maher EA, Schoenfeld S, Zhao D, Pandya SS, Steelman L, Hassan I, Wen PY, Cloughesy TF (2023 Aug) Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma. N Engl J Med 389(7):589\u2013601. https:\/\/doi.org\/10.1056\/NEJMoa2304194","journal-title":"N Engl J Med"},{"key":"5779_CR99","doi-asserted-by":"publisher","unstructured":"Schiff D (2024 Aug) Low-grade gliomas. Neurology 103(3). https:\/\/doi.org\/10.1212\/WNL.0000000000209688","DOI":"10.1212\/WNL.0000000000209688"},{"issue":"2","key":"5779_CR100","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3892\/ijo.2020.5158","volume":"58","author":"S Pan","year":"2020","unstructured":"Pan S, Fan M, Liu Z, Li X, Wang H (2020) Serine, glycine and one\u2011carbon metabolism in cancer (review). Int J Oncol 58(2):158\u2013170. https:\/\/doi.org\/10.3892\/ijo.2020.5158","journal-title":"Int J Oncol"},{"key":"5779_CR101","doi-asserted-by":"publisher","unstructured":"Scott AJ et al. (2023 Oct. 25) Rewiring of cortical glucose metabolism fuels human brain cancer growth. https:\/\/doi.org\/10.1101\/2023.10.24.23297489","DOI":"10.1101\/2023.10.24.23297489"},{"issue":"7962","key":"5779_CR102","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41586-023-06061-0","volume":"617","author":"H Yuan","year":"2023","unstructured":"Yuan H, Wu X, Wu Q, Chatoff A, Megill E, Gao J, Huang T, Duan T, Yang K, Jin C, Yuan F, Wang S, Zhao L, Zinn PO, Abdullah KG, Zhao Y, Snyder NW, Rich JN (2023 May) Lysine catabolism reprograms tumour immunity through histone crotonylation. Nature 617(7962):818\u2013826. https:\/\/doi.org\/10.1038\/s41586-023-06061-0","journal-title":"Nature"},{"issue":"1","key":"5779_CR103","doi-asserted-by":"publisher","first-page":"12700","DOI":"10.1038\/ncomms12700","volume":"7","author":"M Carbonneau","year":"2016","unstructured":"Carbonneau M, M. Gagn\u00e9 L, Lalonde M-E, Germain M-A, Motorina A, Guiot M-C, Secco B, Vincent EE, Tumber A, Hulea L, Bergeman J, Oppermann U, Jones RG, Laplante M, Topisirovic I, Petrecca K, Huot M-\u00c9, Mallette FA (2016 Sep) The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway. Nat Commun 7(1):12700. https:\/\/doi.org\/10.1038\/ncomms12700","journal-title":"Nat Commun"},{"key":"5779_CR104","doi-asserted-by":"publisher","unstructured":"Yamashita AS, da Costa Rosa M, Stumpo V, Rais R, Slusher BS, Riggins GJ (2021) The glutamine antagonist prodrug JHU-083 slows malignant glioma growth and disrupts mTOR signaling. Neuro-Oncol Adv 3(1). https:\/\/doi.org\/10.1093\/noajnl\/vdaa149","DOI":"10.1093\/noajnl\/vdaa149"},{"issue":"9","key":"5779_CR105","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1158\/1078-0432.CCR-18-3729","volume":"25","author":"PE Hall","year":"2019","unstructured":"Hall PE, Lewis R, Syed N, Shaffer R, Evanson J, Ellis S, Williams M, Feng X, Johnston A, Thomson JA, Harris FP, Jena R, Matys T, Jefferies S, Smith K, Wu B-W, Bomalaski JS, Crook T, O\u2019Neill K, Paraskevopoulos D, Khadeir RS, Sheaff M, Pacey S, Plowman PN, Szlosarek PW (2019 May) A phase I study of pegylated arginine deiminase (Pegargiminase), cisplatin, and pemetrexed in argininosuccinate synthetase 1-deficient recurrent high-grade glioma. Clin Cancer Res 25(9):2708\u20132716. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-3729","journal-title":"Clin Cancer Res"},{"key":"5779_CR106","doi-asserted-by":"publisher","first-page":"111593","DOI":"10.1016\/j.cellsig.2025.111593","volume":"127","author":"J Xia","year":"2025","unstructured":"Xia J, Liu W, Ni Y, Shahzad A, Cui K, Xu Z, Zhang J, Wei Z, Teng Z, Yang Z, Zhang Q (2025 Mar) Advances in the impact of ASS1 dysregulation on metabolic reprogramming of tumor cells. Cellular Signalling 127:111593. https:\/\/doi.org\/10.1016\/j.cellsig.2025.111593","journal-title":"Cellular Signalling"},{"issue":"12","key":"5779_CR107","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1002\/ijc.25202","volume":"126","author":"B Delage","year":"2010","unstructured":"Delage B, Fennell DA, Nicholson L, McNeish I, Lemoine NR, Crook T, Szlosarek PW (2010 Jun) Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer. Intl J Cancer 126(12):2762\u20132772. https:\/\/doi.org\/10.1002\/ijc.25202","journal-title":"Intl J Cancer"},{"issue":"14","key":"5779_CR108","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1158\/0008-5472.CAN-25-4773","volume":"86","author":"R Nagel","year":"2026","unstructured":"Nagel R, Kochavi A, Flem-Karlsen K, Adhikary M, Gal-On Y, Klaoudatou MG, Champagne J, Valcanover L, Palashati H, Nielsen MM, Feng X, K\u00f6rner P-R, Giebel L, Yang W, Velds A, Hoekman L, Bleijerveld OB, van Tellingen O, Olweus J, Agami R (2026 Jul) Arginine deprivation of ASS1-deficient cancers drives mistranslation and shared neoepitope production. Cancer Res 86(14):3480\u20133501. https:\/\/doi.org\/10.1158\/0008-5472.CAN-25-4773","journal-title":"Cancer Res"},{"issue":"1","key":"5779_CR109","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1038\/s41467-020-17750-z","volume":"11","author":"LF Campesato","year":"2020","unstructured":"Campesato LF, Budhu S, Tchaicha J, Weng C-H, Gigoux M, Cohen IJ, Redmond D, Mangarin L, Pourpe S, Liu C, Zappasodi R, Zamarin D, Cavanaugh J, Castro AC, Manfredi MG, McGovern K, Merghoub T, Wolchok JD (2020 Aug) Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine. Nat Commun 11(1):4011. https:\/\/doi.org\/10.1038\/s41467-020-17750-z","journal-title":"Nat Commun"},{"issue":"1","key":"5779_CR110","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41392-019-0103-4","volume":"5","author":"L Du","year":"2020","unstructured":"Du L, Xing Z, Tao B, Li T, Yang D, Li W, Zheng Y, Kuang C, Yang Q (2020 Feb) Both IDO1 and TDO contribute to the malignancy of gliomas via the kyn\u2013AhR\u2013AQP4 signaling pathway. Sig Transduct Target Ther 5(1):10. https:\/\/doi.org\/10.1038\/s41392-019-0103-4","journal-title":"Sig Transduct Target Ther"},{"issue":"3","key":"5779_CR111","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s11060-025-05106-w","volume":"174","author":"A Jacquerie","year":"2025","unstructured":"Jacquerie A, Macamo A, Hoeben A, Eekers DBP, Postma AA, Vanmechelen M, De Smet F, Ackermans L, Anten M, Verduin M, Severens K, zur Hausen A, Beckervordersandforth J, Broen MPG (2025 Sep) IDO2-AhR axis as central regulator of the kynurenine pathway in glioblastoma. J Neurooncol 174(3):721\u2013731. https:\/\/doi.org\/10.1007\/s11060-025-05106-w","journal-title":"J Neurooncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05779-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05779-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05779-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:01:40Z","timestamp":1792087300000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05779-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":111,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5779"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05779-x","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics and consent to participate declarations","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.","order":2,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"90"}}